Pharmacologic enhancement of glymphatic flow to treat chronic pain
Bidragets beskrivning
Pain and pain-related conditions cause the highest burden of disease and are the leading cause of disability globally. Discovery of the glymphatic system provides new perspectives into the pathogenesis of chronic pain and opportunities for its treatment and prevention. The glymphatic system is active under natural deep sleep enabling the cerebrospinal fluid to flow through the brain and to clear the central nervous system of accumulated waste. This multidisciplinary preclinical study will be performed in rodents using state-of the art methods, such as a novel single-photon emission tomography tracking of cerebrospinal fluid flow. We will assess the hypothesis that pain-induced poor sleep leads to impaired glymphatic flow, poor clearance of proinflammatory cytokines, neuroinflammation, and consolidation of the chronic pain state. Ultimately, we will study if preclinically identified glymphatic enhancers could be used in rescuing glymphatic flow to alleviate chronic pain.
Visa merStartår
2022
Slutår
2026
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Kliniska forskare
Utlysning
Beslutfattare
Forskningsrådet för biovetenskap, hälsa och miljö
30.05.2022
30.05.2022
Övriga uppgifter
Finansieringsbeslutets nummer
350371
Vetenskapsområden
Biomedicinska vetenskaper
Forskningsområden
Biolääketieteet
Identifierade teman
brain, neuroscience